Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases nextdigitalhealth.com

Shift Bioscience, a biotechnology startup using generative AI to explore how gene activation can reverse the aging process, has secured $16 million in seed funding to further develop its cell simulation AI platform.

The funding round was led by BGF, with significant contributions from Kindred Capital, F-Prime Capital, and Jonathan Milner.